Switch to Dark

Pricing

Learn

RMD logo

RMD - Resmed Inc

362


$233.50

$2.89 (1.253%)
At market close

$233.84

$0.34 (0.143%)
After Hours 3/17/26, 11:00 PM
Stock Unlock LogoScore

4.12/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Income Statement Summary
Metrics
5
KPIs
View as %
Resmed Inc logo

Resmed Inc

Stock Unlock Logo
Stock Unlock
Sign Up
Legend
CAGR
Total Change
Average
Median
Low
High
Latest
Total Revenue
13.69%
10.15%
$1.35B
$1.34B
$1.29B
2025-03-31
$1.42B
2025-12-31
$1.42B
2025-12-31
Operating Expenses
16.3%
12.05%
$360.81M
$360.99M
$340.14M
2025-03-31
$381.13M
2025-12-31
$381.13M
2025-12-31
Net Interest Income Expense
--
--
$3.46M
$4.29M
-$4.52M
2025-03-31
$9.77M
2025-12-31
$9.77M
2025-12-31
Income Tax Expense
145%
96.68%
$83.20M
$88.30M
$52.65M
2025-03-31
$103.56M
2025-12-31
$103.56M
2025-12-31
Cost of Goods Sold (COGS)
4.77%
3.57%
$528.40M
$527.38M
$514.76M
2025-09-30
$544.08M
2025-12-31
$544.08M
2025-12-31
Income Statement
Balance Sheet
Cash Flow
Metrics
KPIs
% Change
Colors
.
#'s in thousands USDAll Time2025-12-312025-09-302025-06-302025-03-312024-12-31
Get more features by creating a free Stock Unlock account:
2 portfolios, 5 positions per portfolio
2 watchlists, up to 10 tickers per watchlist
More screener searches
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
Total Revenue
1,422,808
1,335,582
1,347,993
1,291,736
42,069,000
8769313
3895007
1419554
16987
3323134
1528194
1270510
143797
8220055
6134375
1969082
97838
2036498
Cost of Goods Sold (COGS)
544,084
514,762
529,437
525,327
42,069,000
1848393
7338150
8899375
2777465
7078930
86375
3612287
8451265
5155461
2518416
1336394
9962244
4563899
Gross Profit
878,724
820,820
818,556
766,409
42,069,000
9341162
9607681
5795032
395315
5548029
4671728
9033980
5029433
186395
9452570
6139895
3725912
2833468
Operating Expenses
381,129
358,473
363,497
340,141
42,069,000
3554822
2874711
6283712
2466723
4871408
5882333
5059331
3072030
5151641
9452658
8263222
9359146
3342868
Research & Development
90,969
87,323
86,444
83,944
42,069,000
2252116
8913751
2440221
1470861
4287382
5091953
8070415
6893331
6709296
6748240
625757
8541434
4545807
Selling, General & Administrative Expenses
278,396
259,194
265,125
245,302
42,069,000
3925433
5635863
3481332
1076287
1771866
115182
9981507
4190764
6057766
87251
1538929
4558005
3639762
Operating Income or Loss
497,595
462,347
455,059
426,268
42,069,000
7728208
4660625
5931469
1682696
2880880
1804535
361005
6654257
5692136
4794157
1955515
422834
3048528
Interest Expense
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Net Interest Income Expense
9,770
4,092
4,492
-4,519
42,069,000
1122719
704648
4407885
4250259
4937637
1293477
968426
9137746
6127108
3438481
8650615
6174747
3138244
Non-Recurring Items
-5,935
-15,810
-519
0
42,069,000
--
9706809
8645660
4446195
--
4684063
8230932
3472399
--
8746752
1390808
2649649
--
Total Other Income/Expense Net
-5,282
-3,836
-979
-4,056
42,069,000
415895
712397
6742710
8624273
8815950
4984987
4190670
4728217
380852
2262843
5563925
3704899
3720051
Income Before Tax
496,148
446,793
458,053
417,693
42,069,000
8862910
4975049
2303529
6034323
4448646
3182227
4230906
3203105
6223603
7121190
8619139
7693455
9645397
Income Tax Expense
103,555
98,257
78,348
52,652
42,069,000
2607156
8487975
7269253
6405344
5514538
2805114
9102255
7815554
5313400
2044227
3048703
8903307
4511338
Earnings
392,593
348,536
379,705
365,041
42,069,000
7539222
4197166
3407533
8857499
6121726
6928283
6163802
6251407
4391276
6308608
2392088
3639877
8211997
Adjusted Net Income
386,658
332,726
379,186
365,041
42,069,000
--
7274356
927723
3266893
--
8031630
3315005
9125106
--
3676809
1367047
4181228
--
Net Income After Taxes
392,593
348,536
379,705
365,041
42,069,000
3855905
459381
3371743
7549476
2040701
5809857
2237889
9619987
7719217
9365253
5082520
1997555
2610631
Diluted Shares Outstanding
146,372
146,899
147,064
147,220
42,069
5162619
3226668
2152038
9125979
171232
1775218
3792726
5283999
310565
1656485
4072570
4648198
4081419
Diluted EPS
2.68
2.37
2.58
2.48
42,069
6455702
584802
5852110
7240034
6956311
5898478
7858358
7194549
1042635
8362592
3667868
7180849
8286710
Adjusted EPS
2.64
2.26
2.58
2.48
42,069
--
7428852
8244580
976036
--
4842228
2508320
244375
--
7989384
1027844
8518748
--
EBITDA
547,480
510,045
518,687
469,944
42,069,000
184332
9196735
3534380
1240133
4418978
2046377
3176101
9672956
4576343
1914387
6625090
7526203
2746706